FHIR IG analytics| Package | hl7.fhir.uv.ebm |
| Resource Type | Group |
| Id | Group-236769.json |
| FHIR Version | R6 |
No resources found
No resources found
Note: links and images are rebased to the (stated) source
Generated Narrative: Group 236769
version: 74; Last updated: 2026-01-29 20:45:14+0000; Language: en
Profile: ConceptualExposureDefinition
Artifact Author: Computable Publishing®: MAGIC-to-FEvIR Converter:
Artifact related artifact: No display for RelatedArtifact (type: part-of; resourceReference: ->display: string (PrimitiveType/Group.extension[1].value[x].resourceReference.display): element = string -> display=string[MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes])
CiteAs:
InterventionDefinition: Sodium-Glucose Transport Protein 2 (SGLT2) inhibitors [Database Entry: FHIR Group Resource]. Contributors: Computable Publishing®: MAGIC-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 236769. Revised 2026-01-29. Available at: https://fevir.net/resources/Group/236769. Computable resource at: https://fevir.net/resources/Group/236769#json.
url: https://fevir.net/resources/Group/236769
identifier: FEvIR Object Identifier/236769, FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-intervention-85394-I-85798
name: Sodium_Glucose_Transport_Protein_2_SGLT2_inhibitors85394_I_85798
title: InterventionDefinition: Sodium-Glucose Transport Protein 2 (SGLT2) inhibitors
status: Active
publisher: Computable Publishing LLC
contact: support@computablepublishing.com
description:
This Group Resource is referenced in an example for the EBMonFHIR Implementation Guide.
| Code | Value[x] |
| Evidence Based Medicine on FHIR Implementation Guide Code System: evidence-communication (Evidence Communication) | ConceptualExposureDefinition |
copyright:
https://creativecommons.org/licenses/by-nc-sa/4.0/
membership: Conceptual
{
"resourceType": "Group",
"id": "236769",
"meta": {
"versionId": "74",
"lastUpdated": "2026-01-29T20:45:14.791Z",
"profile": [
"http://hl7.org/fhir/uv/ebm/StructureDefinition/conceptual-exposure-definition"
]
},
"language": "en",
"text": {
"status": "extensions",
"div": "<!-- snip (see above) -->"
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-author",
"valueContactDetail": {
"name": "Computable Publishing®: MAGIC-to-FEvIR Converter"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-relatedArtifact",
"valueRelatedArtifact": {
"type": "part-of",
"resourceReference": {
"type": "Composition",
"identifier": {
"type": {
"text": "FEvIR Linking Identifier"
},
"system": "https://fevir.net/FLI",
"value": "MAGIC-5288-j1Wqrn-conversion-report",
"assigner": {
"display": "Computable Publishing LLC"
}
},
"display": "MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes"
}
}
},
{
"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/cite-as",
"valueMarkdown": "InterventionDefinition: Sodium-Glucose Transport Protein 2 (SGLT2) inhibitors [Database Entry: FHIR Group Resource]. Contributors: Computable Publishing®: MAGIC-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 236769. Revised 2026-01-29. Available at: https://fevir.net/resources/Group/236769. Computable resource at: https://fevir.net/resources/Group/236769#json."
}
],
"url": "https://fevir.net/resources/Group/236769",
"identifier": [
{
"type": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0203",
"code": "ACSN",
"display": "Accession ID"
}
],
"text": "FEvIR Object Identifier"
},
"system": "https://fevir.net/FOI",
"value": "236769",
"assigner": {
"display": "Computable Publishing LLC"
}
},
{
"type": {
"text": "FEvIR Linking Identifier"
},
"system": "https://fevir.net/FLI",
"value": "MAGIC-5288-j1Wqrn-intervention-85394-I-85798",
"assigner": {
"display": "Computable Publishing LLC"
}
}
],
"name": "Sodium_Glucose_Transport_Protein_2_SGLT2_inhibitors85394_I_85798",
"title": "InterventionDefinition: Sodium-Glucose Transport Protein 2 (SGLT2) inhibitors",
"status": "active",
"publisher": "Computable Publishing LLC",
"contact": [
{
"telecom": [
{
"system": "email",
"value": "support@computablepublishing.com"
}
]
}
],
"description": "This Group Resource is referenced in an example for the EBMonFHIR Implementation Guide.",
"useContext": [
{
"code": {
"system": "https://fevir.net/resources/CodeSystem/179423",
"code": "evidence-communication",
"display": "Evidence Communication"
},
"valueCodeableConcept": {
"coding": [
{
"system": "https://fevir.net/resources/CodeSystem/179423",
"code": "ConceptualExposureDefinition",
"display": "ConceptualExposureDefinition"
}
]
}
}
],
"copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/",
"membership": "conceptual"
}